Search

everythinglearnresearchcommunity

for

Search:↓

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Platelet-rich plasma treatments help hair growth in people with hair loss by increasing certain cell growth and protein levels.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Genetic factors play a major role in acne.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

Taking 2.5mg of finasteride daily can effectively improve hair loss in 62% of women, especially those pre-menopause or with less severe hair loss.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

Cyclooxygenase-2 overexpression in mice skin causes hair loss like human androgenetic alopecia.

Possible link between COVID-19 and hair loss; more research needed.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

The treatment increased hair growth and thickness in patients with hair loss.

Tiny pollution particles called PM2.5 can harm skin cells by causing stress, damage to cell parts, and cell death.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Pollution increases a compound in the skin that can lead to faster aging and more inflammation.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.